慢性丙型肝炎合并脂肪肝的发病机制

慢性丙型肝炎(CHC)合并脂肪肝是CHC患者的主要临床表现,脂肪肝对CHC患者病情发展及其抗病毒疗效都有重要影响,归纳了近年来CHC患者并发脂肪肝的病毒和宿主方面的因素及脂肪肝对CHC患者预后的影响。CHC合并脂肪肝的发生机制仍然有待于进一步深入研究。...

Full description

Saved in:
Bibliographic Details
Published in临床肝胆病杂志 Vol. 31; no. 2; pp. 288 - 290
Main Author 魏芳芳 张晓红
Format Journal Article
LanguageChinese
Published 中山大学附属第三医院,广州,510000 2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:慢性丙型肝炎(CHC)合并脂肪肝是CHC患者的主要临床表现,脂肪肝对CHC患者病情发展及其抗病毒疗效都有重要影响,归纳了近年来CHC患者并发脂肪肝的病毒和宿主方面的因素及脂肪肝对CHC患者预后的影响。CHC合并脂肪肝的发生机制仍然有待于进一步深入研究。
Bibliography:WEI Fangfang, ZHANG Xiaohong. ( The Third Affiliated Hospital, Sun Yat -sen University, Guangzhou 510000, China)
hepatitis C, chronic ; fatty liver ; review
Liver steatosis is a frequent histological feature in patients with chronic hepatitis C ( CHC ), and it is associated with the progression of CHC and antiviral efficacy. This paper reviews recent research advances in the viral and host factors involved in the pathogenesis of steatosis among CHC patients and the prognostic impact of steatosis. The pathogenesis of liver steatosis in CHC patients needs further studies.
22-1108/R
ISSN:1001-5256
DOI:10.3969/j.issn.1001-5256.2015.02.038